Meeting report : Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021
Copyright © 2021..
The Global Forum on Tuberculosis (TB) Vaccines was held virtually from 20 to 22 April 2021, marking its 20th anniversary. The Global Forum on TB Vaccines is the world's largest gathering of stakeholders striving to develop new vaccines to prevent TB. The program included more than 60 speakers in 11 scientific sessions, panel discussions, and workshops. It provided an overview of the state of the field, and an opportunity to share the latest research findings, as well as new and innovative approaches to TB vaccine research and development (R&D). This year, it was held against the backdrop of the COVID-19 pandemic and convened researchers, developers, funders, and other stakeholders remotely to discuss opportunities and challenges for TB vaccine R&D in these unprecedented times.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
---|---|
Enthalten in: |
Vaccine - 39(2021), 50 vom: 08. Dez., Seite 7223-7229 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Suliman, Sara [VerfasserIn] |
---|
Links: |
---|
Themen: |
BCG |
---|
Anmerkungen: |
Date Completed 09.12.2021 Date Revised 14.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.vaccine.2021.08.094 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM330804405 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM330804405 | ||
003 | DE-627 | ||
005 | 20240214232341.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.vaccine.2021.08.094 |2 doi | |
028 | 5 | 2 | |a pubmed24n1292.xml |
035 | |a (DE-627)NLM330804405 | ||
035 | |a (NLM)34538522 | ||
035 | |a (PII)S0264-410X(21)01154-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Suliman, Sara |e verfasserin |4 aut | |
245 | 1 | 0 | |a Meeting report |b Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.12.2021 | ||
500 | |a Date Revised 14.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021. | ||
520 | |a The Global Forum on Tuberculosis (TB) Vaccines was held virtually from 20 to 22 April 2021, marking its 20th anniversary. The Global Forum on TB Vaccines is the world's largest gathering of stakeholders striving to develop new vaccines to prevent TB. The program included more than 60 speakers in 11 scientific sessions, panel discussions, and workshops. It provided an overview of the state of the field, and an opportunity to share the latest research findings, as well as new and innovative approaches to TB vaccine research and development (R&D). This year, it was held against the backdrop of the COVID-19 pandemic and convened researchers, developers, funders, and other stakeholders remotely to discuss opportunities and challenges for TB vaccine R&D in these unprecedented times | ||
650 | 4 | |a Clinical Conference | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a BCG | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Funding | |
650 | 4 | |a Pandemic | |
650 | 4 | |a Pipeline | |
650 | 4 | |a Tuberculosis | |
650 | 4 | |a Vaccine | |
650 | 7 | |a Tuberculosis Vaccines |2 NLM | |
700 | 1 | |a Pelzer, Puck T |e verfasserin |4 aut | |
700 | 1 | |a Shaku, Moagi |e verfasserin |4 aut | |
700 | 1 | |a Rozot, Virginie |e verfasserin |4 aut | |
700 | 1 | |a Mendelsohn, Simon C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Vaccine |d 1985 |g 39(2021), 50 vom: 08. Dez., Seite 7223-7229 |w (DE-627)NLM012600105 |x 1873-2518 |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:2021 |g number:50 |g day:08 |g month:12 |g pages:7223-7229 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.vaccine.2021.08.094 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 39 |j 2021 |e 50 |b 08 |c 12 |h 7223-7229 |